search results for

refine results

sort by


result type


Press Releases

Here's how gamers and analysts are reacting to Nintendo's Switch

Many hardcore gamers celebrated the unveiling of Nintendo's new console. But not everyone was wowed.


PayPal CFO: We are a leader in fintech

PayPal CFO John Rainey discusses the company's earnings, partnerships with Alibaba and credit card players as well as competition in the e-commerce and fintech space.


Early movers: GE, HON, STI, COH, MSFT, RAI, AMD, SKX, SLB & more

These are the stocks posting the largest moves before the bell.


Nintendo shares slide 6.5% on teaser for its Switch console…but don’t count it out just yet

Nintendo shares tanked 6.5 percent on Friday following a trailer teasing its new Switch console which analysts said underwhelmed investors.


Asia markets slip as traders digest China home prices, quake hits Japan, typhoon shuts HK

Markets in Asia were lower on Friday as China's home prices rose, a typhoon shut down the Hong Kong market and an earthquake struck Japan.


Priority is to rebuild trust in Mitsubishi: Ghosn

Carlos Ghosn, CEO of Nissan Motor, talks about how he plans to tackle Mitsubishi's image after a mileage-fixing scandal


Here's what the West gets wrong about China, according to Alibaba and Didi execs

Critics who say there is a bubble in the Chinese economy are getting a lot wrong, two tech industry leaders said on Thursday.


Nintendo wants to fix with Switch console what it messed up with Wii U

After the rather disastrous performance of the Wii U, Nintendo will explore new waters next March with its new console — the Nintendo Switch.


Asia markets mostly up; Mexican peso strengthens after conclusion of US Presidential debate

Asian markets were mostly up and the Mexican peso strengthened against the dollar on Thursday following the conclusion of the final U.S. Presidential debate.


Mega pharma mergers haven’t brought value: CEO

Actelion wants to create value in its industry and the best way is to innovate as well as discover and develop new drugs says CEO, Jean-Paul Clozel, when weighing in on potential M&A opportunities.